Lynx1 Capital Management LP Centessa Pharmaceuticals PLC Transaction History
Lynx1 Capital Management LP
- $257 Million
- Q4 2024
A detailed history of Lynx1 Capital Management LP transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Lynx1 Capital Management LP holds 17,400 shares of CNTA stock, worth $253,866. This represents 0.11% of its overall portfolio holdings.
Number of Shares
17,400
Previous 17,400
-0.0%
Holding current value
$253,866
Previous $278,000
4.68%
% of portfolio
0.11%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
117Shares Held
124MCall Options Held
7KPut Options Held
220K-
Medicxi Ventures Management (Jersey) LTD20MShares$291 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$145 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$141 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$92.6 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$84.7 Million9.51% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.38B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...